nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C8—Levothyroxine—hypothyroidism	0.142	0.42	CbGbCtD
Triazolam—CYP2C8—Liotrix—hypothyroidism	0.139	0.41	CbGbCtD
Triazolam—CYP3A4—Levothyroxine—hypothyroidism	0.0578	0.17	CbGbCtD
Triazolam—Menstruation irregular—Levothyroxine—hypothyroidism	0.018	0.0433	CcSEcCtD
Triazolam—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.018	0.0433	CcSEcCtD
Triazolam—GABRQ—nerve—hypothyroidism	0.0171	0.0801	CbGeAlD
Triazolam—GABRR3—nerve—hypothyroidism	0.0171	0.0801	CbGeAlD
Triazolam—GABRR2—nerve—hypothyroidism	0.0149	0.0694	CbGeAlD
Triazolam—GABRR1—nerve—hypothyroidism	0.0143	0.0668	CbGeAlD
Triazolam—Menstruation irregular—Liotrix—hypothyroidism	0.0133	0.0319	CcSEcCtD
Triazolam—Disorientation—Levothyroxine—hypothyroidism	0.00811	0.0195	CcSEcCtD
Triazolam—Disorientation—Dextrothyroxine—hypothyroidism	0.00811	0.0195	CcSEcCtD
Triazolam—Hypertension—Liothyronine—hypothyroidism	0.00768	0.0184	CcSEcCtD
Triazolam—Affect lability—Levothyroxine—hypothyroidism	0.00714	0.0171	CcSEcCtD
Triazolam—Affect lability—Dextrothyroxine—hypothyroidism	0.00714	0.0171	CcSEcCtD
Triazolam—Tachycardia—Liothyronine—hypothyroidism	0.00708	0.017	CcSEcCtD
Triazolam—Irritability—Dextrothyroxine—hypothyroidism	0.00692	0.0166	CcSEcCtD
Triazolam—Irritability—Levothyroxine—hypothyroidism	0.00692	0.0166	CcSEcCtD
Triazolam—Mood swings—Dextrothyroxine—hypothyroidism	0.00687	0.0165	CcSEcCtD
Triazolam—Mood swings—Levothyroxine—hypothyroidism	0.00687	0.0165	CcSEcCtD
Triazolam—Lightheadedness—Liotrix—hypothyroidism	0.00658	0.0158	CcSEcCtD
Triazolam—CYP2C9—urine—hypothyroidism	0.00654	0.0306	CbGeAlD
Triazolam—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0064	0.0154	CcSEcCtD
Triazolam—Muscular weakness—Levothyroxine—hypothyroidism	0.0064	0.0154	CcSEcCtD
Triazolam—Sweating increased—Dextrothyroxine—hypothyroidism	0.00611	0.0147	CcSEcCtD
Triazolam—Sweating increased—Levothyroxine—hypothyroidism	0.00611	0.0147	CcSEcCtD
Triazolam—Disorientation—Liotrix—hypothyroidism	0.00596	0.0143	CcSEcCtD
Triazolam—Affect lability—Liotrix—hypothyroidism	0.00525	0.0126	CcSEcCtD
Triazolam—Irritability—Liotrix—hypothyroidism	0.00509	0.0122	CcSEcCtD
Triazolam—Mood swings—Liotrix—hypothyroidism	0.00505	0.0121	CcSEcCtD
Triazolam—CYP3A4—urine—hypothyroidism	0.00499	0.0233	CbGeAlD
Triazolam—Muscular weakness—Liotrix—hypothyroidism	0.0047	0.0113	CcSEcCtD
Triazolam—GABRG3—pituitary gland—hypothyroidism	0.00466	0.0218	CbGeAlD
Triazolam—Sweating increased—Liotrix—hypothyroidism	0.00449	0.0108	CcSEcCtD
Triazolam—Tension—Levothyroxine—hypothyroidism	0.00429	0.0103	CcSEcCtD
Triazolam—Tension—Dextrothyroxine—hypothyroidism	0.00429	0.0103	CcSEcCtD
Triazolam—Nervousness—Dextrothyroxine—hypothyroidism	0.00424	0.0102	CcSEcCtD
Triazolam—Nervousness—Levothyroxine—hypothyroidism	0.00424	0.0102	CcSEcCtD
Triazolam—Tremor—Levothyroxine—hypothyroidism	0.00409	0.00983	CcSEcCtD
Triazolam—Tremor—Dextrothyroxine—hypothyroidism	0.00409	0.00983	CcSEcCtD
Triazolam—Agitation—Levothyroxine—hypothyroidism	0.00401	0.00964	CcSEcCtD
Triazolam—Agitation—Dextrothyroxine—hypothyroidism	0.00401	0.00964	CcSEcCtD
Triazolam—GABRA4—heart—hypothyroidism	0.00389	0.0182	CbGeAlD
Triazolam—Palpitations—Dextrothyroxine—hypothyroidism	0.00386	0.00927	CcSEcCtD
Triazolam—Palpitations—Levothyroxine—hypothyroidism	0.00386	0.00927	CcSEcCtD
Triazolam—Anxiety—Levothyroxine—hypothyroidism	0.00371	0.0089	CcSEcCtD
Triazolam—Anxiety—Dextrothyroxine—hypothyroidism	0.00371	0.0089	CcSEcCtD
Triazolam—GABRB1—pituitary gland—hypothyroidism	0.0036	0.0168	CbGeAlD
Triazolam—Confusional state—Dextrothyroxine—hypothyroidism	0.00359	0.00863	CcSEcCtD
Triazolam—Confusional state—Levothyroxine—hypothyroidism	0.00359	0.00863	CcSEcCtD
Triazolam—Shock—Levothyroxine—hypothyroidism	0.00351	0.00842	CcSEcCtD
Triazolam—Shock—Dextrothyroxine—hypothyroidism	0.00351	0.00842	CcSEcCtD
Triazolam—Tachycardia—Levothyroxine—hypothyroidism	0.00348	0.00835	CcSEcCtD
Triazolam—Tachycardia—Dextrothyroxine—hypothyroidism	0.00348	0.00835	CcSEcCtD
Triazolam—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00345	0.00828	CcSEcCtD
Triazolam—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00345	0.00828	CcSEcCtD
Triazolam—GABRG3—testis—hypothyroidism	0.00344	0.0161	CbGeAlD
Triazolam—GABRR1—testis—hypothyroidism	0.00328	0.0153	CbGeAlD
Triazolam—GABRA4—pituitary gland—hypothyroidism	0.00325	0.0152	CbGeAlD
Triazolam—GABRP—pituitary gland—hypothyroidism	0.00322	0.0151	CbGeAlD
Triazolam—Insomnia—Levothyroxine—hypothyroidism	0.00322	0.00774	CcSEcCtD
Triazolam—Insomnia—Dextrothyroxine—hypothyroidism	0.00322	0.00774	CcSEcCtD
Triazolam—Dyspnoea—Levothyroxine—hypothyroidism	0.00318	0.00763	CcSEcCtD
Triazolam—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00318	0.00763	CcSEcCtD
Triazolam—Flatulence—Liotrix—hypothyroidism	0.00317	0.0076	CcSEcCtD
Triazolam—Tension—Liotrix—hypothyroidism	0.00315	0.00757	CcSEcCtD
Triazolam—Dysgeusia—Liotrix—hypothyroidism	0.00315	0.00756	CcSEcCtD
Triazolam—GABRR2—cerebellum—hypothyroidism	0.00315	0.0147	CbGeAlD
Triazolam—Nervousness—Liotrix—hypothyroidism	0.00312	0.00749	CcSEcCtD
Triazolam—Fatigue—Levothyroxine—hypothyroidism	0.00307	0.00738	CcSEcCtD
Triazolam—Fatigue—Dextrothyroxine—hypothyroidism	0.00307	0.00738	CcSEcCtD
Triazolam—Tremor—Liotrix—hypothyroidism	0.00301	0.00723	CcSEcCtD
Triazolam—Agitation—Liotrix—hypothyroidism	0.00295	0.00709	CcSEcCtD
Triazolam—GABRE—heart—hypothyroidism	0.00295	0.0138	CbGeAlD
Triazolam—Feeling abnormal—Levothyroxine—hypothyroidism	0.00294	0.00705	CcSEcCtD
Triazolam—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00294	0.00705	CcSEcCtD
Triazolam—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00291	0.007	CcSEcCtD
Triazolam—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00291	0.007	CcSEcCtD
Triazolam—Syncope—Liotrix—hypothyroidism	0.00288	0.00692	CcSEcCtD
Triazolam—GABRA3—thyroid gland—hypothyroidism	0.00287	0.0134	CbGeAlD
Triazolam—GABRD—testis—hypothyroidism	0.00285	0.0133	CbGeAlD
Triazolam—TSPO—adrenal cortex—hypothyroidism	0.00284	0.0133	CbGeAlD
Triazolam—Palpitations—Liotrix—hypothyroidism	0.00284	0.00682	CcSEcCtD
Triazolam—CYP3A7—liver—hypothyroidism	0.00282	0.0132	CbGeAlD
Triazolam—Loss of consciousness—Liotrix—hypothyroidism	0.00282	0.00678	CcSEcCtD
Triazolam—Abdominal pain—Levothyroxine—hypothyroidism	0.00282	0.00677	CcSEcCtD
Triazolam—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00282	0.00677	CcSEcCtD
Triazolam—Hypertension—Liotrix—hypothyroidism	0.00277	0.00666	CcSEcCtD
Triazolam—TSPO—heart—hypothyroidism	0.00275	0.0129	CbGeAlD
Triazolam—Chest pain—Liotrix—hypothyroidism	0.00274	0.00657	CcSEcCtD
Triazolam—Anxiety—Liotrix—hypothyroidism	0.00273	0.00655	CcSEcCtD
Triazolam—GABRG2—pituitary gland—hypothyroidism	0.00272	0.0127	CbGeAlD
Triazolam—GABRA5—testis—hypothyroidism	0.00265	0.0124	CbGeAlD
Triazolam—Confusional state—Liotrix—hypothyroidism	0.00264	0.00635	CcSEcCtD
Triazolam—GABRD—cerebellum—hypothyroidism	0.00263	0.0123	CbGeAlD
Triazolam—Oedema—Liotrix—hypothyroidism	0.00262	0.0063	CcSEcCtD
Triazolam—TSPO—cardiovascular system—hypothyroidism	0.0026	0.0121	CbGeAlD
Triazolam—Shock—Liotrix—hypothyroidism	0.00258	0.00619	CcSEcCtD
Triazolam—Tachycardia—Liotrix—hypothyroidism	0.00256	0.00615	CcSEcCtD
Triazolam—Asthenia—Levothyroxine—hypothyroidism	0.00256	0.00614	CcSEcCtD
Triazolam—Asthenia—Dextrothyroxine—hypothyroidism	0.00256	0.00614	CcSEcCtD
Triazolam—Hyperhidrosis—Liotrix—hypothyroidism	0.00253	0.00609	CcSEcCtD
Triazolam—GABRG1—cerebellum—hypothyroidism	0.00253	0.0118	CbGeAlD
Triazolam—Pruritus—Dextrothyroxine—hypothyroidism	0.00252	0.00606	CcSEcCtD
Triazolam—Pruritus—Levothyroxine—hypothyroidism	0.00252	0.00606	CcSEcCtD
Triazolam—GABRA6—cerebellum—hypothyroidism	0.00252	0.0118	CbGeAlD
Triazolam—Anorexia—Liotrix—hypothyroidism	0.0025	0.006	CcSEcCtD
Triazolam—GABRB3—heart—hypothyroidism	0.0025	0.0117	CbGeAlD
Triazolam—GABRA3—testis—hypothyroidism	0.00246	0.0115	CbGeAlD
Triazolam—GABRE—pituitary gland—hypothyroidism	0.00246	0.0115	CbGeAlD
Triazolam—GABRB1—cerebellum—hypothyroidism	0.00246	0.0115	CbGeAlD
Triazolam—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00244	0.00586	CcSEcCtD
Triazolam—Diarrhoea—Levothyroxine—hypothyroidism	0.00244	0.00586	CcSEcCtD
Triazolam—CYP3A7-CYP3A51P—liver—hypothyroidism	0.0024	0.0112	CbGeAlD
Triazolam—Insomnia—Liotrix—hypothyroidism	0.00237	0.0057	CcSEcCtD
Triazolam—TSPO—gonad—hypothyroidism	0.00236	0.011	CbGeAlD
Triazolam—Paraesthesia—Liotrix—hypothyroidism	0.00235	0.00565	CcSEcCtD
Triazolam—Dyspnoea—Liotrix—hypothyroidism	0.00234	0.00561	CcSEcCtD
Triazolam—TSPO—pituitary gland—hypothyroidism	0.0023	0.0107	CbGeAlD
Triazolam—Decreased appetite—Liotrix—hypothyroidism	0.00228	0.00547	CcSEcCtD
Triazolam—Vomiting—Levothyroxine—hypothyroidism	0.00227	0.00544	CcSEcCtD
Triazolam—Vomiting—Dextrothyroxine—hypothyroidism	0.00227	0.00544	CcSEcCtD
Triazolam—Fatigue—Liotrix—hypothyroidism	0.00226	0.00543	CcSEcCtD
Triazolam—Dermatitis—Dextrothyroxine—hypothyroidism	0.00225	0.00539	CcSEcCtD
Triazolam—Dermatitis—Levothyroxine—hypothyroidism	0.00225	0.00539	CcSEcCtD
Triazolam—Constipation—Liotrix—hypothyroidism	0.00224	0.00538	CcSEcCtD
Triazolam—Headache—Levothyroxine—hypothyroidism	0.00223	0.00536	CcSEcCtD
Triazolam—Headache—Dextrothyroxine—hypothyroidism	0.00223	0.00536	CcSEcCtD
Triazolam—GABRA2—adrenal gland—hypothyroidism	0.00222	0.0104	CbGeAlD
Triazolam—GABRA4—cerebellum—hypothyroidism	0.00222	0.0104	CbGeAlD
Triazolam—GABRE—adrenal gland—hypothyroidism	0.0022	0.0103	CbGeAlD
Triazolam—Feeling abnormal—Liotrix—hypothyroidism	0.00216	0.00519	CcSEcCtD
Triazolam—Gastrointestinal pain—Liotrix—hypothyroidism	0.00214	0.00515	CcSEcCtD
Triazolam—GABRB3—gonad—hypothyroidism	0.00214	0.00999	CbGeAlD
Triazolam—GABRE—thyroid gland—hypothyroidism	0.00212	0.00992	CbGeAlD
Triazolam—Nausea—Dextrothyroxine—hypothyroidism	0.00212	0.00508	CcSEcCtD
Triazolam—Nausea—Levothyroxine—hypothyroidism	0.00212	0.00508	CcSEcCtD
Triazolam—GABRB3—pituitary gland—hypothyroidism	0.00209	0.00975	CbGeAlD
Triazolam—Abdominal pain—Liotrix—hypothyroidism	0.00207	0.00498	CcSEcCtD
Triazolam—TSPO—adrenal gland—hypothyroidism	0.00205	0.00959	CbGeAlD
Triazolam—TSPO—blood—hypothyroidism	0.00205	0.00959	CbGeAlD
Triazolam—GABRE—female gonad—hypothyroidism	0.00205	0.00958	CbGeAlD
Triazolam—GABRB2—testis—hypothyroidism	0.00201	0.00938	CbGeAlD
Triazolam—TSPO—thyroid gland—hypothyroidism	0.00198	0.00926	CbGeAlD
Triazolam—Hypersensitivity—Liotrix—hypothyroidism	0.00193	0.00464	CcSEcCtD
Triazolam—TSPO—female gonad—hypothyroidism	0.00191	0.00894	CbGeAlD
Triazolam—Asthenia—Liotrix—hypothyroidism	0.00188	0.00452	CcSEcCtD
Triazolam—Pruritus—Liotrix—hypothyroidism	0.00185	0.00445	CcSEcCtD
Triazolam—GABRG2—cerebellum—hypothyroidism	0.00185	0.00866	CbGeAlD
Triazolam—GABRB2—cerebellum—hypothyroidism	0.00185	0.00866	CbGeAlD
Triazolam—GABRE—testis—hypothyroidism	0.00182	0.0085	CbGeAlD
Triazolam—GABRB3—thyroid gland—hypothyroidism	0.0018	0.0084	CbGeAlD
Triazolam—Diarrhoea—Liotrix—hypothyroidism	0.00179	0.00431	CcSEcCtD
Triazolam—Dizziness—Liotrix—hypothyroidism	0.00173	0.00416	CcSEcCtD
Triazolam—TSPO—testis—hypothyroidism	0.0017	0.00793	CbGeAlD
Triazolam—GABRA2—cerebellum—hypothyroidism	0.00169	0.00791	CbGeAlD
Triazolam—CYP2C9—heart—hypothyroidism	0.00168	0.00783	CbGeAlD
Triazolam—Vomiting—Liotrix—hypothyroidism	0.00167	0.004	CcSEcCtD
Triazolam—Dermatitis—Liotrix—hypothyroidism	0.00165	0.00397	CcSEcCtD
Triazolam—Headache—Liotrix—hypothyroidism	0.00164	0.00394	CcSEcCtD
Triazolam—GABRA1—cerebellum—hypothyroidism	0.00164	0.00765	CbGeAlD
Triazolam—TSPO—liver—hypothyroidism	0.00161	0.0075	CbGeAlD
Triazolam—CYP2C9—cardiovascular system—hypothyroidism	0.00158	0.00739	CbGeAlD
Triazolam—CYP2C8—pituitary gland—hypothyroidism	0.00158	0.00737	CbGeAlD
Triazolam—TSPO—cerebellum—hypothyroidism	0.00157	0.00733	CbGeAlD
Triazolam—Nausea—Liotrix—hypothyroidism	0.00156	0.00374	CcSEcCtD
Triazolam—GABRB3—testis—hypothyroidism	0.00154	0.0072	CbGeAlD
Triazolam—GABRB3—liver—hypothyroidism	0.00146	0.00681	CbGeAlD
Triazolam—GABRB3—cerebellum—hypothyroidism	0.00142	0.00665	CbGeAlD
Triazolam—CYP2C8—blood—hypothyroidism	0.00141	0.00658	CbGeAlD
Triazolam—CYP3A5—blood—hypothyroidism	0.00127	0.00594	CbGeAlD
Triazolam—CYP2C9—blood—hypothyroidism	0.00125	0.00585	CbGeAlD
Triazolam—CYP3A5—female gonad—hypothyroidism	0.00119	0.00554	CbGeAlD
Triazolam—CYP2C8—testis—hypothyroidism	0.00116	0.00544	CbGeAlD
Triazolam—CYP2C8—liver—hypothyroidism	0.0011	0.00515	CbGeAlD
Triazolam—CYP3A5—liver—hypothyroidism	0.000994	0.00465	CbGeAlD
Triazolam—CYP2C9—liver—hypothyroidism	0.000978	0.00457	CbGeAlD
Triazolam—CYP3A4—blood—hypothyroidism	0.000954	0.00446	CbGeAlD
Triazolam—CYP3A4—liver—hypothyroidism	0.000746	0.00349	CbGeAlD
Triazolam—GABRR1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000555	0.0183	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000529	0.0175	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000529	0.0175	CbGpPWpGaD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000475	0.0157	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000453	0.015	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000453	0.015	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000439	0.0145	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000436	0.0144	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000429	0.0142	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—SLC5A7—hypothyroidism	0.000425	0.014	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000406	0.0134	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—SLC5A7—hypothyroidism	0.000405	0.0134	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—SLC5A7—hypothyroidism	0.000405	0.0134	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000401	0.0132	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000373	0.0123	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000368	0.0121	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000367	0.0121	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000357	0.0118	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000356	0.0118	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00035	0.0115	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000348	0.0115	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000344	0.0113	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000344	0.0113	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000342	0.0113	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000341	0.0113	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000341	0.0113	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000335	0.0111	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—SLC5A7—hypothyroidism	0.000334	0.011	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—SLC5A7—hypothyroidism	0.000329	0.0109	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000314	0.0104	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.000311	0.0103	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.000307	0.0101	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000305	0.0101	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0003	0.0099	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000295	0.00973	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000293	0.00968	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000293	0.00966	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000287	0.00949	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000283	0.00933	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000281	0.00927	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000281	0.00927	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000277	0.00913	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—NEFL—hypothyroidism	0.000274	0.00904	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.000273	0.00901	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.000268	0.00885	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000263	0.00869	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.000262	0.00864	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000262	0.00864	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—NEFL—hypothyroidism	0.000261	0.00862	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—NEFL—hypothyroidism	0.000261	0.00862	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000258	0.00853	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000257	0.00848	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000251	0.00829	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000236	0.0078	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00023	0.00758	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000228	0.00754	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000225	0.00744	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000225	0.00741	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000222	0.00731	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00022	0.00726	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000218	0.00719	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000218	0.00719	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000216	0.00713	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—NEFL—hypothyroidism	0.000215	0.0071	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—NEFL—hypothyroidism	0.000212	0.00699	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—NEFL—hypothyroidism	0.0002	0.00662	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000198	0.00653	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000189	0.00625	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000189	0.00623	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000181	0.00598	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000181	0.00596	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000181	0.00596	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000179	0.00592	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000177	0.00583	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000176	0.00581	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000173	0.0057	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—NEFL—hypothyroidism	0.00017	0.0056	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—NEFL—hypothyroidism	0.000169	0.00557	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000167	0.00552	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000166	0.00547	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000165	0.00545	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000151	0.00499	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000149	0.00491	CbGpPWpGaD
Triazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000148	0.00487	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000147	0.00484	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000146	0.00483	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000145	0.00479	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000145	0.00478	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000144	0.00476	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000142	0.00467	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000141	0.00464	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000139	0.00457	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000138	0.00456	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000137	0.00452	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000125	0.00413	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000122	0.00401	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000121	0.00399	CbGpPWpGaD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00012	0.00395	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000119	0.00394	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000117	0.00387	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000117	0.00385	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000114	0.00378	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000113	0.00371	CbGpPWpGaD
Triazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000107	0.00352	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.0001	0.0033	CbGpPWpGaD
Triazolam—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.25e-05	0.00305	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.13e-05	0.00301	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.71e-05	0.00288	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.71e-05	0.00288	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.65e-05	0.00286	CbGpPWpGaD
Triazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.53e-05	0.00248	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—IYD—hypothyroidism	7.5e-05	0.00248	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.5e-05	0.00247	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—AVP—hypothyroidism	7.19e-05	0.00237	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.17e-05	0.00237	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.07e-05	0.00233	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—AVP—hypothyroidism	6.86e-05	0.00226	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.86e-05	0.00226	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.69e-05	0.00221	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.6e-05	0.00218	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ATP5O—hypothyroidism	6.38e-05	0.00211	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—POMC—hypothyroidism	6.36e-05	0.0021	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.1e-05	0.00201	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.04e-05	0.00199	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TPO—hypothyroidism	6e-05	0.00198	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.87e-05	0.00194	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.76e-05	0.0019	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.66e-05	0.00187	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—AVP—hypothyroidism	5.65e-05	0.00186	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.62e-05	0.00186	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.56e-05	0.00184	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.52e-05	0.00182	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—IYD—hypothyroidism	5.42e-05	0.00179	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	5.26e-05	0.00174	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	5.2e-05	0.00172	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.96e-05	0.00164	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.83e-05	0.00159	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.75e-05	0.00157	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—IYD—hypothyroidism	4.7e-05	0.00155	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	4.62e-05	0.00152	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ATP5O—hypothyroidism	4.61e-05	0.00152	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—POMC—hypothyroidism	4.6e-05	0.00152	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	4.53e-05	0.0015	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.46e-05	0.00147	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	4.43e-05	0.00146	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.35e-05	0.00144	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TPO—hypothyroidism	4.34e-05	0.00143	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.02e-05	0.00133	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ATP5O—hypothyroidism	3.99e-05	0.00132	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—POMC—hypothyroidism	3.98e-05	0.00131	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IYD—hypothyroidism	3.82e-05	0.00126	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.8e-05	0.00125	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TPO—hypothyroidism	3.76e-05	0.00124	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.48e-05	0.00115	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ATP5O—hypothyroidism	3.25e-05	0.00107	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—POMC—hypothyroidism	3.24e-05	0.00107	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TPO—hypothyroidism	3.06e-05	0.00101	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.83e-05	0.000935	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TSHB—hypothyroidism	2.78e-05	0.000917	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IYD—hypothyroidism	2.52e-05	0.000832	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	2.48e-05	0.000817	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.14e-05	0.000708	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.14e-05	0.000705	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC5A5—hypothyroidism	2.08e-05	0.000686	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TPO—hypothyroidism	2.02e-05	0.000665	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TSHB—hypothyroidism	2.01e-05	0.000663	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.79e-05	0.000591	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TSHB—hypothyroidism	1.74e-05	0.000574	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.55e-05	0.000512	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.53e-05	0.000505	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.5e-05	0.000496	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TSHB—hypothyroidism	1.42e-05	0.000467	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.3e-05	0.00043	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.26e-05	0.000416	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.24e-05	0.000411	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—POMC—hypothyroidism	1.09e-05	0.000359	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.06e-05	0.00035	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TSHB—hypothyroidism	9.33e-06	0.000308	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	8.32e-06	0.000275	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—POMC—hypothyroidism	7.86e-06	0.00026	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A5—hypothyroidism	6.99e-06	0.000231	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—POMC—hypothyroidism	6.81e-06	0.000225	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—POMC—hypothyroidism	5.54e-06	0.000183	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—POMC—hypothyroidism	3.65e-06	0.000121	CbGpPWpGaD
